9 patents currently held
174 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2031. from the record
Of the 174 now held by other companies, 171 name Labrador Diagnostics LLC as their current owner, and 3 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2031
Next term end
5
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Sep 2031 · Medium confidence
Also notable
Ends Sep 2033 · High confidence
Also notable
Ends Sep 2035 · High confidence
Also notable
Ends Apr 2037 · High confidence
Also notable
Ends no later than Aug 2033 · Medium confidence
Systems and Methods for Multi-Analysis
US 11,009,516
The most cited patent in this portfolio, cited by 50 later US patents, top 5% of utility patents granted in 2021 in our data. Protection runs to 2031.
Systems, Devices, and Methods for Bodily Fluid Sample Collection, Transport, and Handling
US 10,248,765
Cited by 18 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2033.
Pathogen and Antimicrobial Resistance Testing
US 10,920,284
Granted 2021. Computed term ends 2035.
Systems and Methods for Analyte Testing and Data Management
US 11,545,241
Cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2037.
Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
US 10,788,409
A family of 9 related applications built on the 2020 grant. Protection runs to 2033. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Formerly held, still cited
Notable
Ends Mar 2032 · Medium confidence
Cited by 196 later US patents, top 1% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
now held by Labrador Diagnostics LLC
Also notable
Ends Oct 2027 · High confidence
Cited by 183 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2027.
now held by Labrador Diagnostics LLC
Also notable
Ends Oct 2028 · Low confidence
Cited by 38 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2028. A terminal disclaimer caps this term to an earlier patent's.
now held by Labrador Diagnostics LLC
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
- 7 terms have ended since Aug 21, 2026
What they patent
The 4 largest of its 5 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Systems and Methods for Analyte Testing and Laboratory Oversight | 5 in force | to Feb 2034 |
| Pathogen and Antimicrobial Resistance Testing | 1 in force | to Sep 2035 |
| Systems, Devices, and Methods for Bodily Fluid Sample Collection, Transport, and Handling | 1 in force | to Sep 2033 |
| Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes | 1 in force | to Aug 2033 |
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,009,516 | Systems and Methods for Multi-Analysis held by Labrador Diagnostics LLC In force · Medium confidence | In force | Medium confidence | |
| US 11,054,432 | Systems and methods for multi-purpose analysis held by Labrador Diagnostics LLC In force · High confidence | In force | High confidence | |
| US 11,524,299 | Systems and Methods for Fluid Handling held by Labrador Diagnostics LLC In force · High confidence | In force | High confidence | |
| US 10,976,330 | Fluid Handling Apparatus and Configurations held by Labrador Diagnostics LLC In force · High confidence | In force | High confidence | |
| US 10,788,409 | Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes held by Labrador Diagnostics LLC In force · Medium confidence | In force | Medium confidence | |
| US 10,248,765 | Systems, Devices, and Methods for Bodily Fluid Sample Collection, Transport, and Handling held by Labrador Diagnostics LLC In force · High confidence | In force | High confidence | |
| US 11,008,628 | Systems and Methods for Analyte Testing and Laboratory Oversight held by Labrador Diagnostics LLC In force · High confidence | In force | High confidence | |
| US 10,920,284 | Pathogen and Antimicrobial Resistance Testing held by Labrador Diagnostics LLC In force · High confidence | In force | High confidence | |
| US 11,545,241 | Systems and Methods for Analyte Testing and Data Management held by Labrador Diagnostics LLC In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 174 patents in force now held by others · 76 patents ended · 10 applications pending · 118 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.